HIGHLIGHTS
- who: Jijing Wang from the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, National Center for Neurological Disorders, Shanghai, China have published the research work: Deamidation-related blood biomarkers show promise for early diagnostics of neurodegeneration, in the Journal: (JOURNAL)
- what: Besides, the majority of blood biomarker characterization studies concerned separating diagnosed AD from healthy controls, while much less results have been published on the more challenging task of diagnosing early neurodegeneration stages, such as mild cognitive impairment (MCI) ahead of diagnosed dementia. Summarizing the previous work and current findings, the authors propose the following . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.